DPLM Diploma PLC
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Europe, North America, and internationally. It operates through three business sectors: Controls, Seals, and Life Sciences. The Controls sector offers wire and cabling, interconnect, specialty fasteners, specialty adhesive and industrial automation solutions for various applications. The Seals sector supplies sealing and fluid power products, gaskets, hoses and fittings, pumps and valves, and solutions for aftermarket repairs, original equipment manufacturing, and maintenance, repair and overhaul projects. The Life Sciences sector supplies and services equipment; provides consumables and instrumentation for surgery, diagnosis of disease, and critical care support; and supplies diagnostic and scientific technologies, surgical instruments, medical devices, endoscopes, patient monitoring equipment, specialist hospital supplies, and clinical nutrition. It serves public and private hospitals, clinics and diagnostics laboratories. Diploma PLC was incorporated in 1999 and is based in London, the United Kingdom.…
Industry Peers
Industrial DistributionKey Statistics
About Diploma (LON: DPLM)
›
Diploma (LON: DPLM) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Industrial Distribution industry, part of the Industrials sector, and reports about 4,000 employees.
The shares were at 6605.00 GBp on 20 November 2026, up 21.0% over 52 weeks.
At a market capitalisation of 8.86B GBP, it trades at 34.6 times trailing earnings and 23.1 times forward earnings. The median trailing P/E of its 18 largest Industrial Distribution peers is 25.9, a premium of 34% for DPLM. It pays a dividend yielding 0.92% (it pays out 44% of its earnings), against a median of 1.31% among the dividend payers in that peer group.
Diploma reports return on equity of 18.7%, an operating margin of 22.5% and revenue up 24.3% year over year.
Its debt exceeds its cash by 452.20M GBP, a debt-to-equity ratio of 0.47. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 16 analysts cover the stock, with an average rating of Buy; their mean price target of 8391.88 GBp is 27.1% above the current price.